Scholars@Duke

Health economics of cardiovascular disease: Defining the research agenda

Publication ,  Journal Article
Ferdinand, KC; Orenstein, D; Hong, Y; Journigan, JG; Trogdon, J; Bowman, J; Zohrabian, A; Kilgore, M; White, A; Mokdad, A; Pechacek, TF ...
Published in: CVD Prevention and Control
September 1, 2011
Published version (DOI)

Background: When allocating limited resources, public and private sector leaders in health policy consider both the health and economic value of new measures for cardiovascular disease (CVD) prevention. The ability to develop and prioritize policy measures is hindered by important gaps in health economics data. Methods and Results: The Policy Research Implementation Group (PRIG) of the National Forum for Heart Disease and Stroke Prevention convened a symposium to develop priorities for research on the economics of CVD primary prevention and elimination of CVD disparities. Suggested top opportunities include expanded CVD surveillance, advances in evaluation and economic modeling of primary prevention, and use of behavioral economics to identify new prevention strategies. Enhanced policy, funding, and leadership support are vital to realizing this research agenda. Conclusions: Targeted research on the health and economic value of CVD prevention, especially to eliminate CVD disparities, would bolster the justification for increased investment in cardiovascular health. © 2011 Published by Elsevier Ltd. on behalf of World Heart Federation.

Duke Scholars

Eric Andrew Finkelstein
Author Eric Andrew Finkelstein Population Health Sciences

Published In

CVD Prevention and Control

DOI

10.1016/j.cvdpc.2011.05.001

EISSN

1875-4562

ISSN

1875-4570

Publication Date

September 1, 2011

Volume

6

Issue

3

Start / End Page

91 / 100

Related Subject Headings

  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ferdinand, K. C., Orenstein, D., Hong, Y., Journigan, J. G., Trogdon, J., Bowman, J., … Vaccarino, V. (2011). Health economics of cardiovascular disease: Defining the research agenda. CVD Prevention and Control, 6(3), 91–100. https://doi.org/10.1016/j.cvdpc.2011.05.001
Ferdinand, K. C., D. Orenstein, Y. Hong, J. G. Journigan, J. Trogdon, J. Bowman, A. Zohrabian, et al. “Health economics of cardiovascular disease: Defining the research agenda.” CVD Prevention and Control 6, no. 3 (September 1, 2011): 91–100. https://doi.org/10.1016/j.cvdpc.2011.05.001.
Ferdinand KC, Orenstein D, Hong Y, Journigan JG, Trogdon J, Bowman J, et al. Health economics of cardiovascular disease: Defining the research agenda. CVD Prevention and Control. 2011 Sep 1;6(3):91–100.
Ferdinand, K. C., et al. “Health economics of cardiovascular disease: Defining the research agenda.” CVD Prevention and Control, vol. 6, no. 3, Sept. 2011, pp. 91–100. Scopus, doi:10.1016/j.cvdpc.2011.05.001.
Ferdinand KC, Orenstein D, Hong Y, Journigan JG, Trogdon J, Bowman J, Zohrabian A, Kilgore M, White A, Mokdad A, Pechacek TF, Goetzel RZ, Labarthe DR, Puckrein GA, Finkelstein E, Wang G, French ME, Vaccarino V. Health economics of cardiovascular disease: Defining the research agenda. CVD Prevention and Control. 2011 Sep 1;6(3):91–100.

Published In

CVD Prevention and Control

DOI

10.1016/j.cvdpc.2011.05.001

EISSN

1875-4562

ISSN

1875-4570

Publication Date

September 1, 2011

Volume

6

Issue

3

Start / End Page

91 / 100

Related Subject Headings

  • 1102 Cardiorespiratory Medicine and Haematology